Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Psoriasis Subjects”

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03451851
What this trial is testing

Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 120
Early research (Phase 1)Study completedNCT03029741
What this trial is testing

Bioavailability of AZD0284 and IV Microtracer Study

Who this might be right for
Plaque Psoriasis Vulgaris
AstraZeneca 6
Testing effectiveness (Phase 2)Study completedNCT01483924
What this trial is testing

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
ApoPharma 60
Post-approval studies (Phase 4)Study completedNCT03403036
What this trial is testing

Brodalumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Failed IL-17A Therapies

Who this might be right for
Psoriasis
Icahn School of Medicine at Mount Sinai 39
Testing effectiveness (Phase 2)Study completedNCT00245765
What this trial is testing

Efficacy Study of CDP870 in Subjects With Chronic Plaque Psoriasis Who Are Candidate for Systemic Therapy and/or Phototherapy/Photochemotherapy

Who this might be right for
Chronic Plaque Psoriasis
UCB Pharma 176
Large-scale testing (Phase 3)Study completedNCT00647400
What this trial is testing

Adalimumab in Adult Japanese Subjects With Psoriasis

Who this might be right for
Psoriasis
Abbott 147
Large-scale testing (Phase 3)Study completedNCT01882647
What this trial is testing

A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)

Who this might be right for
Plaque Psoriasis
Therapeutics, Inc. 222
Post-approval studies (Phase 4)Study completedNCT00437255
What this trial is testing

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

Who this might be right for
Plaque Psoriasis
Galderma R&D 122
Testing effectiveness (Phase 2)Study completedNCT03837743
What this trial is testing

Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Durect 25
Not applicableStudy completedNCT00708708
What this trial is testing

Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings

Who this might be right for
Psoriasis
Pfizer 926
Large-scale testing (Phase 3)Study completedNCT02074982
What this trial is testing

Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Type Psoriasis
Novartis Pharmaceuticals 676
Testing effectiveness (Phase 2)Study completedNCT04655313
What this trial is testing

Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)

Who this might be right for
PsoriasisPlaque Psoriasis
Arcutis Biotherapeutics, Inc. 20
Post-approval studies (Phase 4)Study completedNCT06333860
What this trial is testing

Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)

Who this might be right for
Moderate Plaque Psoriasis
AbbVie 393
Large-scale testing (Phase 3)Study completedNCT05108766
What this trial is testing

A Phase Ⅲ Study to Evaluate Tildrakizumab in the Treatment of Chinese Subjects With Moderate to Severe Plaquetype Psoriasis

Who this might be right for
Plaque Psoriasis
Shenzhen Kangzhe Pharmaceutical Co., Ltd. 220
Large-scale testing (Phase 3)Study completedNCT02748863
What this trial is testing

Study of Secukinumab With 2 mL Pre-filled Syringes

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 214
Large-scale testing (Phase 3)Study completedNCT01186744
What this trial is testing

Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 666
Testing effectiveness (Phase 2)Study completedNCT02852967
What this trial is testing

A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Kadmon Corporation, LLC 110
Testing effectiveness (Phase 2)Study completedNCT02905006
What this trial is testing

Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma S.P.R.L. 250
Large-scale testing (Phase 3)Study completedNCT04713592
What this trial is testing

Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar Involvement

Who this might be right for
Psoriasis
AbbVie 174
Large-scale testing (Phase 3)Study completedNCT06108544
What this trial is testing

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

Who this might be right for
Plaque Psoriasis
Takeda 1,108
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation